Skip to content

Clinical trials

Obesity trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: Singapore Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20092
20105
20111
20121
20131
20143
20153
20162
20175
20189
20196
20203
20215
20227
20236
20243
20258
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Unknown status17
Recruiting12
Active, not recruiting6
Not yet recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Singapore Institute of Food and Biotechnology Innovation14
Eli Lilly and Company11
National University Hospital, Singapore8
National University of Singapore6
Nanyang Technological University5
Changi General Hospital4
KK Women's and Children's Hospital4
Singapore General Hospital4
Duke-NUS Graduate Medical School3
Sengkang General Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity80
Overweight24
Diabetes Mellitus, Type 213
Diabetes Mellitus10
Glucose Intolerance6
Weight Loss6
Hypertension4
Insulin Resistance4
Inflammation3
Metabolic Diseases3

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.